'New Era' of Type 2 Diabetes Treatment as LEADER Unveiled? - Medscape

Medscape

'New Era' of Type 2 Diabetes Treatment as LEADER Unveiled? Medscape NEW ORLEANS — Details of the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results—A Long Term Evaluation (LEADER) trial of the glucose-lowering drug liraglutide (Victoza, Novo Nordisk), showing that it significantly ... Novo diabetes drug cuts heart risks by 13 percent in key trialReuters This Diabetes Drug Saves Lives. You Can Thank The FDAForbes GLP-1 Drug Cuts Heart Risk in DiabetesMedPage Today TCTMD -FiercePharma -EndocrineWeb all 10 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNHNkdwKhd4nBcgr0h9SJDOcmfslHg&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779132748187&ei=8StfV9jNIoe13gGJ_4PoBw&url=http://www.medscape.com/viewarticle/864729
via IFTTT